» Articles » PMID: 34610197

Relationships Between Obstructive Sleep Apnea Syndrome and Cardiovascular Risk in a Naïve Population of Southern Italy

Overview
Publisher Wiley
Specialty General Medicine
Date 2021 Oct 5
PMID 34610197
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obstructive sleep apnea (OSA) is a worldwide increasing syndrome, which, by promoting endothelial dysfunction, contributes to extend the cardiovascular risk. We evaluated the cardiovascular risk in a group of OSA patients.

Methods: A total of 185 OSA subjects (19 normal weight, 57 overweight, 109 obese), who entered the Ambulatory of Sleep Disorders of the Institute of Respiratory Diseases of the University of Bari, during 1 year, were enrolled in the study. We assessed anthropometric features, polysomnographic findings, cardiovascular risk factors, smoking habit, Pulmonary Function Test, Arterial Blood Gas Analysis, Epworth Questionnaire, and Charlson Co-morbidities Index (CCI). Subjects were divided into three groups, according to their BMI: individuals with BMI ≥30 kg/m (Group 1 n = 109, mean age 61 ± 1; 74.3% men), individuals with BMI ranging from 25.0 to 29.9 kg/m defined as overweight subjects (Group 2 n = 57, mean age 58.8 ± 1.4; 77% men), and subjects with a BMI ranging from 18.5 to 24.9 kg/m defined as normal weight subjects (Group 3 n = 19, mean age 54.2 ± 2.3; 64,2% men).

Results: In the whole population, the percentage cardiovascular risk was weakly related with BMI (r = 0.33; P < .001), but not with AHI. The cardiovascular risk was strictly related to the obesity (P < .00002), while the Epworth Questionnaire score and the Charlson Co-morbidity Index were respectively statistically higher in the group of obese individuals (P = .004, P = .0002) than in the other two sub-groups. When AHI values were stratified in tertiles, the percentage cardiovascular risk did not vary with increasing AHI values (Figure 2).

Conclusions: Further studies are required to investigate the pivotal role of inflammation resulting from obesity, and underlying increased cardiovascular risk in OSA patients.

Citing Articles

One Year Follow-Up Assessment of Impact of Rigorous Diet Regimen and Adequate C-PAP Therapy on Obese Patients with Obstructive Sleep Apnea Syndrome: A Retrospective Study.

Carratu P, Dragonieri S, Quaranta V, Resta O, Portincasa P, Palmieri V J Clin Med. 2024; 13(21).

PMID: 39518499 PMC: 11546787. DOI: 10.3390/jcm13216360.


The impact of continuous positive airway pressure therapy on cardiovascular events in patients with obstructive sleep apnoea: an updated systematic review and meta-analysis.

Feng G, Zhuge P, Zhang Z, Ma J Sleep Breath. 2024; 28(5):2095-2105.

PMID: 39083193 DOI: 10.1007/s11325-024-03107-z.


Obstructive Sleep Apnea Syndrome and Obesity Indicators, Circulating Blood Lipid Levels, and Adipokines Levels: A Bidirectional Two-Sample Mendelian Randomization Study.

Zhang Y, Wang H, Yang J, Wang S, Tong W, Teng B Nat Sci Sleep. 2024; 16:573-583.

PMID: 38827393 PMC: 11143989. DOI: 10.2147/NSS.S460989.


Cardiovascular Outcome in Patients with Major Depression: Role of Obstructive Sleep Apnea Syndrome, Insomnia Disorder, and COMISA.

Hein M, Wacquier B, Conenna M, Lanquart J, Point C Life (Basel). 2024; 14(5).

PMID: 38792664 PMC: 11123427. DOI: 10.3390/life14050644.


Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among Hypertensive Patients.

Li Y, Shataer R, Chen Y, Zhu X, Sun X Med Sci Monit. 2024; 30:e942667.

PMID: 38771735 PMC: 11127607. DOI: 10.12659/MSM.942667.


References
1.
Carratu P, Carratu L, Resta O . What is more affected in patients wit obstructive sleep apnea: the right or the left heart?. Pol Arch Med Wewn. 2016; 126(4):217-8. DOI: 10.20452/pamw.3384. View

2.
Punjabi N, Sorkin J, Katzel L, Goldberg A, Schwartz A, Smith P . Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002; 165(5):677-82. DOI: 10.1164/ajrccm.165.5.2104087. View

3.
Hotamisligil G . Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6):900-17. PMC: 2887297. DOI: 10.1016/j.cell.2010.02.034. View

4.
Leung C, Moondra V, Catherwood E, Andrus B . Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol. 2010; 106(2):284-6. DOI: 10.1016/j.amjcard.2010.02.039. View

5.
Zamanian R, Hansmann G, Snook S, Lilienfeld D, Rappaport K, Reaven G . Insulin resistance in pulmonary arterial hypertension. Eur Respir J. 2008; 33(2):318-24. PMC: 2785883. DOI: 10.1183/09031936.00000508. View